ERF 📈 Eurofins Scientific SE - Overview

Exchange: PA • Country: Luxembourg • Currency: EUR • Type: Common Stock • ISIN: FR0014000MR3

ERF: Testing, Certification, Laboratory, Analytical, Services, Diagnostics

Eurofins Scientific SE is a global leader in providing analytical testing and laboratory services, offering a comprehensive portfolio of methods and tests to assess the safety, identity, composition, and purity of various products. The company's services span multiple industries, including agroscience, where it provides biological assessment, consumer and human safety, environmental safety, product chemistry, and regulatory consultancy, among others. Its agro testing services help ensure the quality and safety of agricultural products, while its assurance services provide product inspection, auditing, certification, and training for the food, consumer products, healthcare, and cosmetics industries.

The company's biopharma and clinical diagnostics services support the development and commercialization of pharmaceuticals and medical devices, while its consumer product testing services help manufacturers ensure compliance with regulatory requirements and industry standards. Eurofins also offers specialized services for the cosmetics and personal care industry, including testing for safety, efficacy, and environmental sustainability. Its environmental testing services cover a range of areas, including water, air, soil, and waste testing, as well as testing for other products such as pesticides and heavy metals. Additionally, the company provides food and feed testing services, including allergen, GMO, and nutritional analysis, to help ensure the safety and quality of food products.

Eurofins' services also extend to audit and certification, training and consulting, food irradiation and labeling, and testing for persistent organic pollutants, veterinary drug residue, and other contaminants. The company's forensic services support law enforcement and legal proceedings, while its genomic services provide DNA analysis and other genetic testing. Eurofins also offers maritime, materials and engineering, and REACH services, among others. With a history dating back to 1987, the company is headquartered in Luxembourg City, Luxembourg, and has established itself as a trusted partner for companies across various industries, providing critical testing and analysis services to support their operations and ensure compliance with regulatory requirements.

As a publicly traded company, Eurofins Scientific SE is listed on the Euronext Paris stock exchange and is classified under the biotechnology sub-industry. Its common stock is traded under the ISIN code FR0014000MR3, and the company's website provides detailed information on its services, history, and operations. With a strong commitment to quality, innovation, and customer satisfaction, Eurofins continues to expand its services and capabilities, supporting the growth and development of various industries worldwide. The company's web presence can be found at https://www.eurofins.com, providing easy access to its range of services and expertise.

Additional Sources for ERF Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ERF Stock Overview

Market Cap in USD 9,488m
Sector Healthcare
Industry Diagnostics & Research
GiC Sub-Industry Biotechnology
IPO / Inception

ERF Stock Ratings

Growth 5y -19.8%
Fundamental 59.5%
Dividend 14.8%
Rel. Strength Industry -1248
Analysts -
Fair Price Momentum 42.59 EUR
Fair Price DCF 120.66 EUR

ERF Dividends

Dividend Yield 12m 1.07%
Yield on Cost 5y 1.09%
Annual Growth 5y -7.40%
Payout Consistency 76.4%

ERF Growth Ratios

Growth Correlation 3m 51.8%
Growth Correlation 12m -66.5%
Growth Correlation 5y -35.6%
CAGR 5y 0.46%
CAGR/Mean DD 5y 0.01
Sharpe Ratio 12m -0.44
Alpha -31.82
Beta 0.57
Volatility 30.37%
Current Volume 382.6k
Average Volume 20d 381.2k
What is the price of ERF stocks?
As of January 21, 2025, the stock is trading at EUR 47.07 with a total of 382,608 shares traded.
Over the past week, the price has changed by -3.96%, over one month by -1.28%, over three months by -12.44% and over the past year by -13.79%.
Is Eurofins Scientific SE a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Eurofins Scientific SE (PA:ERF) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 59.51 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ERF as of January 2025 is 42.59. This means that ERF is currently overvalued and has a potential downside of -9.52%.
Is ERF a buy, sell or hold?
Eurofins Scientific SE has no consensus analysts rating.
What are the forecast for ERF stock price target?
According to ValueRays Forecast Model, ERF Eurofins Scientific SE will be worth about 46.3 in January 2026. The stock is currently trading at 47.07. This means that the stock has a potential downside of -1.66%.
Issuer Forecast Upside
Wallstreet Target Price 59.5 26.3%
Analysts Target Price - -
ValueRay Target Price 46.3 -1.7%